Abstract Background The Milan system for Reporting Salivary Gland Cytopathology
(MSRSGC) was published in 2018. Since then, many authors have published their …

Background The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC)
reports a 25% rate of malignancy (ROM) for the Milan I: Nondiagnostic (ND) category. We …

The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) was introduced in
2018 following other organ specific cytopathological reporting systems and it aimed at …

Objective: The Milan System for Reporting Salivary Gland Cytology (MSRSGC) has been
recently published to help communication between cytopathologists and clinicians. The aim …

Background: Fine-needle aspiration cytology (FNAC) of the salivary gland is crucial in the
identification of salivary gland lesions, but the variation in morphological pattern and the …

Background This study aims to assess in our institutional experience the accuracy of fine
needle aspiration cytology (FNAC) in the diagnosis of salivary gland masses (SGM) …

Introduction Salivary gland neoplasms account for approximately 5% of head and neck
tumours. The cytomorphology of fine needle aspiration material helps determine the …

Aim: The aim is to analyze the risk of neoplasia (RON) and risk of malignancy (ROM) of
Milan's category III (AUS) by subdividing into six groups based on cytolomorphology …

Introduction: Salivary gland tumors (SGT) represent 6 to 8 percent of head and neck tumors.
The cytologic diagnosis of SGT is performed by fine-needle aspiration cytology (FNAC) with …

Background Fine needle aspiration cytology (FNAC) is an established technique in the
management of salivary gland lesions. The Milan System for reporting salivary gland …